OVIDOvid Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of Ovid Therapeutics Inc. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OVIDEsta | $479M#7 | — | 2.3x#4 | 66.1x#10 | 1181.3%#1 | 34.1%#5 | -585.2%#10 | -8.3%#7 | — | — | 75.4%#5 | — |
| PBYI | $531M#1 | 20.2x#3 | 3.8x#9 | 2.3x#4 | -0.9%#8 | 2.8%#9 | 16.3%#2 | 22.5%#3 | — | — | 101.6%#2 | — |
| GYRE | $530M#2 | — | 4.9x#10 | 4.5x#6 | 10.2%#5 | -44.8%#14 | 9.9%#3 | 9.2%#4 | 12.0%#1 | 3#3 | -33.4%#12 | 8.5%#1 |
| IMMX | $527M#3 | — | 2.3x#5 | — | — | -36.0%#12 | — | -12.8%#10 | — | — | 94.2%#3 | — |
| FBIOP | — | 5.5x#2 | — | — | 9.7%#6 | 76.2%#3 | -111.0%#8 | 22.5%#2 | — | — | 120.9%#1 | — |
| DMAC | $496M#4 | — | 12.9x#11 | 991.2x#11 | — | -34.0%#11 | -6879.4%#12 | -85.5%#12 | — | — | 30.4%#6 | — |
| ARVN | $487M#5 | 28.7x#4 | 0.9x#1 | 1.9x#3 | -0.3%#7 | 59.3%#4 | -45.1%#6 | -14.4%#11 | -25.3%#4 | — | -26.5%#11 | — |
| CBIO | $481M#6 | — | 2.9x#7 | 44.3x#9 | — | 306.4%#2 | -1407.5%#11 | 0.1%#5 | — | — | 1.7%#8 | — |
| FTH | $478M#8 | — | 2.8x#6 | — | — | 30.1%#7 | — | -12.2%#9 | -15.2%#3 | — | 90.3%#4 | — |
| EOLS | $474M#9 | — | — | 1.6x#2 | 11.6%#4 | -2.4%#10 | -11.0%#4 | — | -40.5%#5 | 4#1 | 11.1%#7 | — |
| CTMX | $466M#10 | — | 1.5x#3 | 6.1x#7 | -44.8%#10 | -154.5%#16 | -29.3%#5 | -5.7%#6 | -7.8%#2 | — | -40.1%#13 | — |
| AQST | $466M#11 | — | — | 10.5x#8 | -22.6%#9 | -89.8%#15 | -159.5%#9 | — | — | — | -45.4%#14 | — |
| MNPR | $449M#12 | — | 3.4x#8 | — | — | 12.0%#8 | — | -10.5%#8 | — | — | -22.0%#10 | — |
| PHAT | $448M#13 | — | — | 2.6x#5 | 216.9%#3 | 33.8%#6 | -91.4%#7 | — | — | 4#1 | -59.3%#16 | — |
| INDP | $420M#14 | — | 36.9x#12 | — | — | -38.8%#13 | — | -183.3%#13 | — | — | -2.8%#9 | — |
| CRMD | $419M#15 | 2.5x#1 | 0.9x#2 | 1.3x#1 | 617.0%#2 | 1009.4%#1 | 48.2%#1 | 35.4%#1 | — | — | -51.7%#15 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice